Transcription profiling of human chromic myeloid leukemia (CML) patients treated second-line with imatinib after failure of an interferon-alpha based therapy to identify genes with predictive value for primary cytogenetic outcome to imatinib

ABSTRACT: Identification of genes in CML patients with predictive value for their primary cytogenetic outcome to imatinib. All samples analyzed were taken just before the start of imatinib treatment. Leukemic patients were treated second-line with imatinib after failure of an interferon-alpha based therapy (first-line regimen).

ORGANISM(S): Homo sapiens

SUBMITTER: Andreas Hochhaus 

PROVIDER: E-MEXP-433 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress